Results 111 to 120 of about 75,341 (263)

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. [PDF]

, 2014
Complex interactions between the immune system and the brain might have important aetiological and therapeutic implications for neuropsychiatric brain disorders.
Cousins, Lesley, Deakin, Julia, Jones, Peter B., Khandaker, Golam M., Lennox, Belinda R., Yolken, Robert   +5 more
core   +2 more sources

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Fluphenazine decanoate (depot) and enanthate for schizophrenia [PDF]

, 2015
Background: Intramuscular injections (depot preparations) offer an advantage over oral medication for treating schizophrenia by reducing poor compliance.
Abuzzahab, Abuzzahab, Abuzzahab, Adamson, Ahlfors, Alarcon, Alarcon, Albert, Altamura, Altamura, Altman, Andreasen, Andreasen, Angst, Angst, Arato, Asarnow, Asberg, Astrup, Balon, Bankier, Bao, Barnes, Barnes, Barnes, Barsa, Bastie, Benassi, Berliner, Bilone, Bland, Bloch, Boissel, Boyer, Breier, Buck, Caranza, Carpenter, Carpenter, Carpenter, Cassady, Chacon, Chacon, Charalampous, Chein, Chien, Childers, Chouinard, Chouinard, Chouinard, Chouinard, Chouinard, Chouinard, Chowdhury, Clark, Cohen, Cole, Cookson, Cookson, Coufal, Crawford, Curry, Curry, Curson, Curson, David, David, Davis, Dencker, Dencker, Dencker, Dencker, Dencker, Dencker, Dengler, DeWolfe, Divine, Donlon, Donlon, Donlon, Donlon, Donner, Doongaji, Dossenbach, Dotti, Downing, Egger, Elbourne, Endicott, Engelhardt, Engstrand, Fallon, Falloon, Faltus, Faretra, Feighner, Feng, Filip, Floru, Floru, Frangos, Furukawa, Gelenberg, Giannelli, Gillis, Gitlin, Gitlin, Giudice, Goff, Goldberg, Goldberg, Goldberg, Goldberg, Goldstein, Gopalakrishnan, Grosser, Gulliford, Guy, Haider, Hall, Hamilton, Hanlon, Harper, Haslam, Haynes, Heinrich, Held, Higgins, Hirsch, Hirsch, Hirsch, Hirsch, Hirsch, Hirsch, Hogarty, Hogarty, Hogarty, Holden, Holt, Honigfeld, Hsu, Hutton, Inderbitzin, Inderbitzin, Ionescu, Iqbal, Irwin, Itil, Itil, Itil, Itil, Jablensky, Jain, Jakovljevic, James, Javed, Johnson, Jolley, Jones, Ju, Jue, Kabes, Kabes, Kabes, Kabes, Kane, Kane, Kane, Kane, Kane, Kane, Kane, Kane, Kaneno, Kay, Kelly, Kenway, Keskiner, Keskiner, Keskiner, Khazaei, Khazaie, King, Kinon, Kinross-Wright, Kissling, Knights, Kong, Krawiecka, Kreisman, Kurland, Kurland, Landmark, Lapierre, Lapierre, Lapierre, Lapierre, Lasky, Leff, Leff, Lehmann, Leong, Leucht, Leucht, Levenson, Levine, Levinson, Levinson, Levinson, Lewis, Lewis, Lingjaerde, Litman, Ljubin, Lundin, Lundin, MacCrimmon, Magnus, Magnus, Mahmoud, Malm, Mandel, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marshall, Martenyi, Martin, Mattes, McClelland, McCreadie, McCreadie, McCreadie, McCreadie, McKane, McLaren, Meco, Mimica, Moher, Montejo, Morris, National Institute of Mental Health Psychopharmacology Service Center Collaborative Study Group, Nestoros, Odejide, Overall, Owen, Palma Wenzel, Pichot, Pickar, Pickar, Pickar, Pinto, Pollack, Praag, Praag, Preussler, Preussler, Putten, Putten, Quitkin, Quitkin, Quitkin, Ravanic, Ravaris, Ravaris, Rifkin, Rifkin, Rifkin, Rifkin, Rifkin, Roose, Rossger, Rossi, Russell, Schausberger, Schipper, Schlosberg, Schneider, Schooler, Schooler, Schooler, Schooler, Schooler, Schooler, Schooler, Schubert, Schünemann, Shafti, Sharma, Shenoy, Shepherd, Shu, Simon, Simpson, Simpson, Singh, Song, Steingard, Stevens, Stevens, Tegeler, Tran, Tretreault, Tsai, Tsai, Turner, Turner, Ukoumunne, Ushakov, Ushakov, Verster, Vestre, Viala, Villeneuve, Vinar, Walker, Weiden, Wiles, Winter, Wistedt, Wistedt, Wistedt, Wistedt, Wistedt, Wistedt, Wistedt, Woggon, Xia, Zapletalek   +336 more
core   +1 more source

Laypeople's Views on the Narrative Identity and Societal Treatment of Genetically Modified People

Bioethics, EarlyView.
ABSTRACT Genome editing in human embryos could raise new ethical issues by changing future people's narrative and numerical identity. Most philosophers agree that some genetic modifications would have larger effects on identity than others, but they disagree on what criteria might explain these differences and have not supported their claims ...
Derek So, Yann Joly, Robert Sladek
wiley   +1 more source

Treatment resistance in schizophrenia [PDF]

British Journal of Psychiatry, 1993
S, Mirza, V S, Babu, E, Vithayathil
openaire   +2 more sources

Prevalence & Prescription: Prescribing Practices of Clozapine in Australia between 2005 & 2010 [PDF]

, 2012
Clozapine is an anti-psychotic used to treat refractory schizophrenia. This study reviews the rates of clozapine prescription for refractory schizophrenia in a region of Australia and compares the prescribing patterns to the estimated prevalence rates of
Pai, NB, Vella, SC
core   +2 more sources

The association between autism and psychosis and the tools used to measure it: An updated systematic review and meta‐analysis

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives Autistic individuals are at increased risk of psychotic experiences and being diagnosed with psychotic disorders. This association may result from methodological issues, including the misinterpretation of psychosis questionnaires by autistic individuals and clinicians' difficulty distinguishing between the conditions.
Michael R. Miles, Dennis Golm, Emma Palmer‐Cooper   +2 more
wiley   +1 more source

Clozapine use decreases the number of hospitalizations per year in patients with treatment-resistant schizophrenia.

Clinical and Biomedical Research, 2021
For years, the management of schizophrenia has represented a challenge for clinicians, with antipsychotic treatments usually resulting in relapses and new hospitalizations.
Marina Dalla Barba Londero, Mathias Hasse-Sousa, Carolina Petry-Perin, Felipe Cesar de Almeida Claudino, Letícia Sanguinetti Czepielewski, Clarissa Severino Gama   +5 more
doaj  

Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report

Frontiers in Psychiatry, 2017
The authors present the case of a 24-year-old male with treatment-resistant schizophrenia, with predominant severe delusion and hallucination, who received bone marrow transplantation (BMT) for acute myeloid leukemia.
Tsuyoshi Miyaoka, Rei Wake, Sadayuki Hashioka, Maiko Hayashida, Arata Oh-Nishi, Ilhamuddin Abdul Azis, Muneto Izuhara, Keiko Tsuchie, Tomoko Araki, Ryosuke Arauchi, Rostia Arianna Abdullah, Jun Horiguchi   +11 more
doaj   +1 more source

Medicaid spending burden among beneficiaries with treatment-resistant depression. [PDF]

, 2019
AIM: To evaluate Medicaid spending and healthcare resource utilization (HRU) in treatment-resistant depression (TRD). MATERIALS & METHODS: TRD beneficiaries were identified from Medicaid claims databases (January 2010-March 2017) and matched 1:1 with ...
Greenberg, Paul E., Jacques, Philippe, Lefebvre, Patrick, Lejeune, Dominique, Pilon, Dominic, Sheehan, John J., Singer, David, Szukis, Holly   +7 more
core   +1 more source